Menlo Park-based venture capital firm 5AM Venture Management has collected $200m for its latest fund, 5AM Ventures III, which will invest in early stage life sciences companies.
The firm raised $119m for the fund in March this year.
5AM's first fund raised $65m in 2002; its second fund raised $150m in 2006.
5AM will continue its focus on early stage life science companies with the majority of the investments being made in the discovery and development of novel therapeutics. A meaningful portion of the fund will also be invested in companies developing diagnostics, materials, medical devices and reagents, the firm said.
Founded in 2002, 5AM has invested in 27 companies.
Copyright © 2009 AltAssets
Article is in the following categories:
Private Equity News» By News Type» Fund News
Private Equity News» By PE Sector» Venture/Growth
Private Equity News» By Region» North America» United States
Private Equity News» By News Type» Fund News
Private Equity News» By PE Sector» Venture/Growth
Private Equity News» By Region» North America» United States









5AM Venture Management collects $200m for third fund